• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail

GRN No. 411

Substance: Egg yolk-derived phospholipids
Intended Use: As an ingredient in term and preterm infant formula at levels up to 2 grams phospholipids per liter of formula, providing a maximum of 0.28% and 0.18% of total fatty acids as arachidonic acid and docosahexaenoic acid, respectively
Basis: Scientific procedures
Notifier: Laurent PHILIPPIN
BNLfood Investments SARL
1, z.a. Salzbaach
L 9559 - Wiltz - LUXEMBOURG
Date of filing: Jan 4, 2012
GRAS Notice (releasable information): 411
Date of closure / FDA's Letter: Nov 20, 2012
FDA has no questions